Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
Marit Jalink(Sanquin), Josephine M. I. Vos(Sanquin), Efstathios Kastritis(AOL (United States)), Henrik Frederiksen(University of Southern Denmark), Jorge J. Castillo(Miriam Hospital), Andrea Patriarca(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Masja de Haas(Dutch Blood Transfusion Society), Ramona Cassin(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Sigbjørn Berentsen(Privatsykehuset Haugesund), Liesbeth E.M. Oosten(Leiden University Medical Center), Bruno Fattizzo(University of Milan), Steven P. Treon(Harvard University), Marjan Cruijsen(Radboud University Nijmegen), Despina Fotiou(National and Kapodistrian University of Athens), Shirley D’Sa(University College London Hospitals NHS Foundation Trust)
Cited by 56
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905